摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(2-aminophenyl)-1-phenylmethanesulfonamide | 182499-87-2

中文名称
——
中文别名
——
英文名称
N-(2-aminophenyl)-1-phenylmethanesulfonamide
英文别名
N-(benzylsulfonyl)-o-phenylenediamine;o-(benzylsulfonylamino)aniline;2-(benzyl sulfonyl amino) aniline;2-(benzyl sulfonyl amino)-aniline;2-(benzyl sulfonyl amino)aniline
N-(2-aminophenyl)-1-phenylmethanesulfonamide化学式
CAS
182499-87-2
化学式
C13H14N2O2S
mdl
MFCD09050932
分子量
262.332
InChiKey
WMWPOLBAWLJWPR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    452.6±55.0 °C(Predicted)
  • 密度:
    1.359±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.076
  • 拓扑面积:
    80.6
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    参考文献:
    名称:
    摘要:
    A new procedure was proposed for synthesis of quinoxaline derivatives by N-alkylation of 2,6-di-tert-butyl-4-(o-R-sulfonylaminophenylimino)-2,5-cyclohexadienones and subsequent intramolecular spiro-cyclization. A necessary condition for the reaction to occur is a high mobility of hydrogen in the N-methylene group, which is activated by electron-acceptor aroyl or two ethoxycarbonyl groups.
    DOI:
    10.1023/a:1012399922502
  • 作为产物:
    参考文献:
    名称:
    Phenyl urea antagonists of the IL-8 receptor
    摘要:
    本发明涉及式(I)的新化合物和这些化合物在治疗趋化因子介导的疾病方面的新用途,其中趋化因子结合到IL-8 a或b受体。式(1)的化合物由以下结构表示:其中,interalia,X是氧或硫;R是具有离子化氢和pKa小于10的任何功能基团;R1独立地选择自氢;卤素;硝基;氰基;C1-C10烷基;卤代C1-10烷基;C2-10烯基;C1-10烷氧基;卤代C1-10烷氧基;叠氮基;(CR8R8)qS(O)tR4;羟基;羟基取代的C1-4烷基;芳基;芳基C1-4烷基;芳基C2-10烯基;芳氧基;芳基C1-4烷氧基;杂芳基;杂芳基烷基;杂芳基C2-10烯基;杂芳基C1-4烷氧基;杂环,杂环C1-4烷基;杂环C1-4烷氧基;杂环C2-10烯基;q为0或具有值为1至10的整数;n为具有值为1至3的整数;m为具有值为1至3的整数;n为具有值为1至3的整数;Y是氢;卤素;硝基;氰基;卤代C1-10烷基;C1-10烷基;C2-10烯基;C1-10烷氧基;卤代C1-1-烷氧基;叠氮基;(CR8R8)qS(O)tR4,(CR8R8)qOR4;羟基;羟基取代的C1-4烷基;芳基;芳基C1-4烷基;芳氧基;芳基C1-4烷氧基;芳基C2-10烯基;杂芳基;杂芳基烷基;杂芳基C1-4烷氧基;杂芳基C2-10烯基;杂环,杂环C1-4烷基;杂环C2-10烯基;或其药学上可接受的盐。
    公开号:
    US06211373B1
点击查看最新优质反应信息

文献信息

  • IL-8 receptor antagonists
    申请人:SmithKline Beecham Corporation
    公开号:US05886044A1
    公开(公告)日:1999-03-23
    This invention relates to the novel use of phenyl ureas in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).
    这项发明涉及苯基化合物在治疗由趋化因子白细胞介素-8(IL-8)介导的疾病状态中的新用途。
  • <i>N</i>-{2-[(3,5-Di-<i>tert</i>-butyl-4-oxocyclohexa-2,5-dien-1-ylidene)amino]phenyl}-<i>N</i>-(5,7-dinitroquinolin-8-yl)-1-phenylmethanesulfonamide: the nature of intramolecular shortened contacts
    作者:Oleg Ya. Borbulevych、Sergey V. Kurbatov、Sergey N. Borisenko、Lev P. Olekhnovich
    DOI:10.1107/s0108270104003439
    日期:2004.4.15
    The title compound, C36H35N5O7S, is found to exist in a nonspirocyclic (ring-opened) form in the crystal, although equilibrium of ring-opened and ring-closed forms ( or so-called ring - chain isomerization) is possible in solution. The 4-oxocyclohexa-2,5-diene ring has a flattened sofa conformation. The N...C intramolecular separation of the atoms which would be directly bonded in a ring-closed form is quite short [2.813 (5) Angstrom]. Topological analysis of charge density based on density-functional-theory calculations was used for consideration of shortened intramolecular contacts and indicates a strong attractive bonding interaction between these N and C atoms in the crystal structure.
  • Tautomerism and Stereodynamics of Indophenols, Amidines, and Their Derivatives and Analogs: XVI. Synthesis of Tetrahydroquinoxalines Having Spiro-Fused Oxoindole and Cyclohepta[c]furan Fragments
    作者:S. V. Kurbatov、D. N. Kuznetsov、V. I. Simakov、V. A. Voronina、Yu. A. Zhdanov、L. P. Olekhnovich
    DOI:10.1023/b:rugc.0000039087.49416.5e
    日期:2004.5
    Alkylation of o-(N-sulfonylamino)phenylimino derivatives of indol-2-one and cyclohepta[c]furan with phenacyl bromides is accompanied by cyclization to previously unknown tetrahydroquinoxalines having spiro-fused oxoindole and cyclohepta[c]furan fragments. The structure of the latter includes a nitrogen-oxygen triangular system typical of most natural cytotoxic compounds.
  • Tautomerism and Stereodynamics of Indophenols, Amidines, and Their Derivatives and Analogs: XV.<sup>1</sup>Cyclization of N-Benzylidene-N'-R-sulfonyl-o-phenylenediamines to Tetrahydroquinoxalines
    作者:S. V. Kurbatov、D. N. Kuznetsov、V. I. Simakov、L. D. Popov、Yu. A. Zhdanov、L. P. Olekhnovich
    DOI:10.1023/b:rugc.0000007659.30597.5c
    日期:2003.8
    Alkylation of N-benzylidene-N'-R-sulfonyl-o-phenylenediamines with phenacyl bromides is accompanied by diastereoselective cyclization to afford tetrahydroquinoxaline derivatives. No cyclization occurs in the alkylation of the same compounds with p-nitrobenzyl bromide or chloroacetamide derivatives because of reduced reactivity of the N-methylene protons.
  • US06005008
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫